David Q. Pham

544 total citations
19 papers, 369 citations indexed

About

David Q. Pham is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Q. Pham has authored 19 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Q. Pham's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Pharmaceutical studies and practices (3 papers). David Q. Pham is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Pharmaceutical studies and practices (3 papers). David Q. Pham collaborates with scholars based in United States. David Q. Pham's co-authors include Roda Plakogiannis, Marie Davies, Daniel A. Nadeau, Ehsan Ullah, S. I. McFarlane, Rupert Payne, Anandi V. Law, Amanda Tran, David I. Min and Karl Hess and has published in prestigious journals such as Clinical Therapeutics, The Journal of Clinical Pharmacology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

David Q. Pham

18 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Q. Pham United States	12	78	76	50	49	43	19	369
Xianhua Li China	13	142 1.8×	95 1.3×	55 1.1×	62 1.3×	19 0.4×	45	522
Abdullah S. Shatoor Saudi Arabia	13	109 1.4×	45 0.6×	67 1.3×	28 0.6×	23 0.5×	39	502
Beniamino Pagliaro Italy	8	120 1.5×	49 0.6×	51 1.0×	30 0.6×	19 0.4×	19	482
Roda Plakogiannis United States	10	50 0.6×	31 0.4×	55 1.1×	42 0.9×	39 0.9×	20	289
Viera Kristová Slovakia	11	47 0.6×	54 0.7×	83 1.7×	24 0.5×	74 1.7×	28	386
Somayyeh Asghari Iran	13	70 0.9×	112 1.5×	104 2.1×	40 0.8×	56 1.3×	35	483
Vivianne Presta Italy	11	28 0.4×	66 0.9×	58 1.2×	29 0.6×	51 1.2×	27	382
Wenfang Ma China	16	157 2.0×	45 0.6×	21 0.4×	52 1.1×	7 0.2×	37	578
Vera Lúcia Portal Brazil	12	58 0.7×	80 1.1×	89 1.8×	50 1.0×	11 0.3×	41	546
D L van der A Netherlands	6	49 0.6×	84 1.1×	136 2.7×	85 1.7×	65 1.5×	7	419

Countries citing papers authored by David Q. Pham

Since Specialization

Citations

This map shows the geographic impact of David Q. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Q. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Q. Pham more than expected).

Fields of papers citing papers by David Q. Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Q. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Q. Pham. The network helps show where David Q. Pham may publish in the future.

Co-authorship network of co-authors of David Q. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of David Q. Pham. A scholar is included among the top collaborators of David Q. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Q. Pham. David Q. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Pham, David Q., et al.. (2025). Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus. Reviews in Endocrine and Metabolic Disorders. 26(4). 559–574.

Tran, Amanda, et al.. (2024). Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes. Journal of Diabetes & Metabolic Disorders. 23(1). 385–394. 5 indexed citations

Davies, Marie, et al.. (2016). GLP1‐RA Add‐on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(8). 893–905. 11 indexed citations

Pham, David Q., et al.. (2015). Inhaled Technosphere Insulin: A Novel Delivery System and Formulation for the Treatment of Types 1 and 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(3). 298–314. 15 indexed citations

Law, Anandi V., et al.. (2012). Impact of a Faculty Orientation and Development Committee. American Journal of Pharmaceutical Education. 76(1). 3–3. 9 indexed citations

Pham, David Q., et al.. (2010). How to manage medications in the setting of liver disease with the application of six questions. International Journal of Clinical Practice. 64(7). 858–867. 4 indexed citations

Pham, David Q., et al.. (2010). Clevidipine for the treatment of severe hypertension in adults. Clinical Therapeutics. 32(1). 11–23. 17 indexed citations

Pham, David Q., et al.. (2008). Rotigotine transdermal system for the treatment of Parkinson's disease. Clinical Therapeutics. 30(5). 813–824. 39 indexed citations

Pham, David Q., et al.. (2008). Sitagliptin: A novel agent for the management of type 2 diabetes mellitus. American Journal of Health-System Pharmacy. 65(6). 521–531. 16 indexed citations

10.

Pham, David Q., et al.. (2007). Inhaled Human [rDNA Origin] Insulin, a Novel Formulation for Diabetes Mellitus. The Journal of Clinical Pharmacology. 47(7). 890–903. 4 indexed citations

11.

Pham, David Q., et al.. (2007). Cinnamon Supplementation in Patients with Type 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(4). 595–599. 35 indexed citations

12.

Pham, David Q., et al.. (2007). Ranolazine: a novel agent that improves dysfunctional sodium channels. International Journal of Clinical Practice. 61(5). 864–872. 11 indexed citations

13.

Pham, David Q., et al.. (2007). Evaluating the appropriateness of thromboprophylaxis in an acute care setting using a computerised reminder, through order-entry system. International Journal of Clinical Practice. 62(1). 134–137. 10 indexed citations

14.

Pham, David Q., et al.. (2007). Interaction potential between cranberry juice and warfarin. American Journal of Health-System Pharmacy. 64(5). 490–494. 35 indexed citations

15.

Pham, David Q., et al.. (2006). Role of abatacept in the management of rheumatoid arthritis. Clinical Therapeutics. 28(11). 1764–1778. 23 indexed citations

16.

Pham, David Q., et al.. (2006). Adjunctive Therapy with Pramlintide in Patients with Type 1 or Type 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1626–1640. 8 indexed citations

17.

Pham, David Q.. (2006). Evaluating the Impact of Clinical Interventions by PharmD Students on Internal Medicine Clerkships: The Results of a 3 Year Study. Annals of Pharmacotherapy. 40(9). 1541–1545. 35 indexed citations

18.

Pham, David Q. & Roda Plakogiannis. (2005). Vitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1. Annals of Pharmacotherapy. 39(11). 1870–1878. 41 indexed citations

19.

Pham, David Q. & Roda Plakogiannis. (2005). Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2. Annals of Pharmacotherapy. 39(12). 2065–2072. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact